Correction: Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow‑up of 14.4 years
Titel:
Correction: Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow‑up of 14.4 years
Auteur:
Kürzel, Sabine Blaudszun, André‑René Stahl, Lilly Herbst, Regina Kroschinsky, Frank Birkmann, Josef Hänel, Annette Schaefer-Eckart, Kerstin Ehninger, Gerhard Fiedler, Friedrich Bornhäuser, Martin Fricke, Stephan Hänel, Mathias